Acinetobacter baumannii in Germany across human, animal, and environmental settings: a systematic review and secondary analysis of national surveillance data
DOI:
https://doi.org/10.66585/ohmi.2026.2.0028Schlagwörter:
Acinetobacter baumannii, Antimicrobial resistance, blaOXA-23, blaNDM, Carbapenem resistance, Germany, One HealthAbstract
Acinetobacter baumannii (A. baumannii) is a leading cause of difficult-to-treat healthcare-associated infections worldwide and has been classified as a priority “1” critical pathogen by the World Health Organization (WHO). Germany reported 811 mandatory notification cases in 2024, with blaNDM detected in 13% of gene-positive notified cases (49/372; 95% CI 10.1%–17.0%). No comprehensive One Health synthesis of German A. baumannii science has previously existed. We conducted four parallel systematic literature searches across thirteen electronic databases, covering research from January 2019 to June 2026 and guided by PRISMA 2020, to identify peer-reviewed German A. baumannii publications across four domains: animals, environment, humans, and resistance gene characterization. In parallel, Acinetobacter-specific data were extracted from six consecutive annual volumes of RKI’s “Infektionsepidemiologisches Jahrbücher” (2019–2024) on Infectious Disease Epidemiology and compared with the peer-reviewed literature across ten parameters. Thirty-two unique peer-reviewed papers were identified: nine animal, twelve environmental, eight human clinical, and fifteen resistance gene characterization. The blaOXA-23 dominated all six surveillance years at 57–66%, and blaNDM surged to 13% of gene-positive notified cases in 2024, with no peer-reviewed characterization of the responsible lineage. Three critical One Health findings emerged: an NDM-1-positive ST25 A. baumannii isolate from an Italian dog processed at a German veterinary laboratory in 2018 predated the 2024 surveillance signal, an epidemiologically unlinked but hypothesis-generating temporal pattern; multidrug resistant (MDR) A. baumannii with clinically associated multilocus sequence typing (MLST) profiles was detected in urban wastewater treatment plants receiving hospital wastewater, without concurrent analysis of patient isolates; and the equine collection contained globally distributed IC1–IC3/ST1–ST3 lineages but did not establish resistance-island identity with German intensive care unit (ICU) strains. No eligible German study simultaneously sampled environmental and human clinical isolates from the same geographic catchment by whole-genome sequencing (WGS). Nineteen research gaps were identified, nine classified as urgent. Germany's animal, environmental, and human clinical A. baumannii research communities operate in parallel without cross-domain genomic linkage. The 2024 blaNDM surveillance signal requires lineage-resolved molecular characterization to determine whether it represents true epidemiological emergence, improved detection, or importation, and to support susceptibility-guided therapy and integrated One Health genomic surveillance.
Literaturhinweise
1. Murray CJL, Ikuta KS, Sharara F, Swetschinski L, Robles Aguilar G, Gray A, et al. Global burden of bacterial antimicrobial resistance in 2019: A systematic analysis. Lancet. 2022;399(10325):629–655. https://doi.org/10.1016/S0140-6736(21)02724-0
2. Jadimurthy R, Mayegowda SB, Nayak SC, Mohan CD, Rangappa KS. Escaping mechanisms of ESKAPE pathogens from antibiotics and their targeting by natural compounds. Biotechnol Rep. 2022;34: 00728. https://doi.org/10.1016/j.btre.2022.e00728
3. Tacconelli E, Carrara E, Savoldi A, Harbarth S, Mendelson M, Monnet DL, et al. Discovery, research, and development of new antibiotics: The WHO priority list of antibiotic-resistant bacteria and tuberculosis. Lancet Infect Dis. 2018;18(3):318–327. https://doi.org/10.1016/S1473-3099(17)30753-3
4. Magiorakos AP, Srinivasan A, Carey RB, Carmeli Y, Falagas ME, Giske CG, et al. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: An international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect. 2012;18(3):268–281. https://doi.org/10.1111/j.1469-0691.2011.03570.x
5. Wareth G, Brandt C, Sprague LD, Neubauer H, Pletz MW. WGS based analysis of acquired antimicrobial resistance in human and non-human Acinetobacter baumannii isolates from a German perspective. BMC Microbiol. 2021;21(1):210. https://doi.org/10.1186/s12866-021-02270-7
6. List of Prokaryotic names with Standing in Nomenclature (LPSN). Genus Acinetobacter. Available from: https://lpsn.dsmz.de/genus/a
cinetobacter. Accessed 2023 Nov.
7. Howard A, O'Donoghue M, Feeney A, Sleator RD. Acinetobacter baumannii: An emerging opportunistic pathogen. Virulence. 2012;3(3):243–250. https://doi.org/10.4161/viru.19700
8. Peleg AY, Seifert H, Paterson DL. Acinetobacter baumannii: Emergence of a successful pathogen. Clin Microbiol Rev. 2008;21(3):538–582. https://doi.org/10.1128/CMR.00058-07
9. Antunes LCS, Visca P, Towner KJ. Acinetobacter baumannii: Evolution of a global pathogen. Pathog Dis. 2014;71(3):292–301. https://doi.org/10.1111/2049-632X.12125
10. World Health Organization. Global priority list of antibiotic-resistant bacteria to guide research, discovery, and development of new antibiotics. Geneva: World Health Organization. 2017. https://www.who.int/medicines/publications/WHO-PPL-Short_Summary_25Feb-ET_NM_WHO.pdf
11. World Health Organization. WHO bacterial priority pathogens list, 2024: Bacterial pathogens of public health importance to guide research, development and strategies to prevent and control antimicrobial resistance. Geneva: World Health Organization. 2024. https://www.who.int/publications/i/item/9789240093461
12. Wohlfarth E, Kresken M, Higgins PG, Stefanik D, Wille J, Hafner D, et al. The evolution of carbapenem resistance determinants and major epidemiological lineages among carbapenem-resistant Acinetobacter baumannii isolates in Germany, 2010–2019. Int J Antimicrob Agents. 2022;60(5–6):106689. https://doi.org/10.1016/j.ijantimicag.2022.106689
13. Müller C, Reuter S, Wille J, Xanthopoulou K, Stefanik D, Grundmann H, et al. A global view on carbapenem-resistant Acinetobacter baumannii. mBio. 2023;14(6):e02260-23. https://doi.org/10.1128/mbio.02260-23
14. Higgins PG, Hagen RM, Podbielski A, Frickmann H, Warnke P. Molecular epidemiology of carbapenem-resistant Acinetobacter baumannii isolated from war-injured patients from the Eastern Ukraine. Antibiotics. 2020;9(9):579. https://doi.org/10.3390/antibiotics9090579
15. Schultze T, Hogardt M, Velázquez ES, Hack D, Besier S, Wichelhaus TA, et al. Molecular surveillance of multidrug-resistant Gram-negative bacteria in Ukrainian patients, Germany, March to June 2022. Euro Surveill. 2023;28(1):2200850. https://doi.org/10.2807/1560-7917.ES.2023.28.1.2200850
16. Turowski P, Cremanns M, Eisfeld J, Gatermann S, Pfennigwerth N. Influence of PER-7 on cefiderocol susceptibility in clinical isolates of Acinetobacter baumannii producing OXA-23 or OXA-72 carbapenemases. JAC Antimicrob Resist. 2025;7(5):dlaf188. https://doi.org/10.1093/jacamr/dlaf188
17. Seifert H, Müller C, Stefanik D, Higgins PG, Miller A, Kresken M. In vitro activity of sulbactam/durlobactam against global isolates of carbapenem-resistant Acinetobacter baumannii. J Antimicrob Chemother. 2020;75(9):2616–2621. https://doi.org/10.1093/jac/dkaa208
18. European Centre for Disease Prevention and Control. Antimicrobial resistance in the EU/EEA (EARS-Net) – Annual epidemiological report for 2022. Stockholm: ECDC. 2023. https://www.ecdc.europa.eu/en/publications-data/surveillance-antimicrobial-resistance-europe-2022
19. Robert Koch-Institut. Infektionsepidemiologisches Jahrbuch meldepflichtiger Krankheiten für 2019. Berlin: Robert Koch-Institut. 2020. Chapter 6.1: Acinetobacter-Infektion oder -Kolonisation, p. 51–54. https://doi.org/10.25646/6948
20. Said D, Willrich N, Ayobami O, Noll I, Eckmanns T, Markwart R. The epidemiology of carbapenem resistance in Acinetobacter baumannii complex in Germany (2014–2018): An analysis of data from the national Antimicrobial Resistance Surveillance system. Antimicrob Resist Infect Control. 2021;10(1):45. https://doi.org/10.1186/s13756-021-00909-8
21. Robert Koch-Institut. Infektionsepidemiologisches Jahrbuch meldepflichtiger Krankheiten für 2024. Berlin: Robert Koch-Institut. 2026. Chapter 6.1: Acinetobacter-Infektion oder -Kolonisation, p. 41–44. https://doi.org/10.25646/13601
22. Robert Koch-Institut. Infektionsepidemiologisches Jahrbuch meldepflichtiger Krankheiten für 2020. Berlin: Robert Koch-Institut. 2021. Chapter 6.1: Acinetobacter-Infektion oder -Kolonisation, p. 43–46. https://doi.org/10.25646/8773
23. Robert Koch-Institut. Infektionsepidemiologisches Jahrbuch meldepflichtiger Krankheiten für 2021. Berlin: Robert Koch-Institut. 2022. Chapter 6.1: Acinetobacter-Infektion oder -Kolonisation, p. 43–46. https://doi.org/10.25646/10143
24. Robert Koch-Institut. Infektionsepidemiologisches Jahrbuch meldepflichtiger Krankheiten für 2022. Berlin: Robert Koch-Institut. 2024. Chapter 6.1: Acinetobacter-Infektion oder -Kolonisation, p. 41–43. https://doi.org/10.25646/12213
25. Robert Koch-Institut. Infektionsepidemiologisches Jahrbuch meldepflichtiger Krankheiten für 2023. Berlin: Robert Koch-Institut. 2025. Chapter 6.1: Acinetobacter-Infektion oder -Kolonisation, p. 41–44. https://doi.org/10.25646/13043
26. Rödenbeck M, Ayobami O, Eckmanns T, Pletz MW, Bleidorn J, Markwart R. Clinical epidemiology and case fatality due to antimicrobial resistance in Germany: A systematic review and meta-analysis, 1 January 2010 to 31 December 2021. Euro Surveill. 2023;28(20):2200672. https://doi.org/10.2807/1560-7917.ES.2023.28.20.2200672
27. Wilharm G, Skiebe E, Michalska A, Higgins PG, Weber K, Schaudinn C, et al. Acinetobacter baumannii's lifestyle includes soil-dwelling colonization of decaying plant material and airborne spread. Nat Commun. 2026;17(1):2316. https://doi.org/10.1038/s41467-026-70072-4
28. Yusuf I, Skiebe E, Wilharm G. Evaluation of CHROMagar Acinetobacter and MacConkey media for the recovery of Acinetobacter baumannii from soil samples. Lett Appl Microbiol. 2023;76(2):ovac051. https://doi.org/10.1093/lambio/ovac051
29. Alexander J, Hembach N, Schwartz T. Evaluation of antibiotic resistance dissemination by wastewater treatment plant effluents with different catchment areas in Germany. Sci Rep. 2020;10(1):8952. https://doi.org/10.1038/s41598-020-65635-4
30. Falgenhauer L, Schwengers O, Schmiedel J, Baars C, Lambrecht O, Heß S, et al. Multidrug-resistant and clinically relevant Gram-negative bacteria are present in German surface waters. Front Microbiol. 2019;10:2779. https://doi.org/10.3389/fmicb.2019.02779
31. Pulami D, Schauss T, Eisenberg T, Wilharm G, Blom J, Goesmann A, et al. Acinetobacter baumannii in manure and anaerobic digestates of German biogas plants. FEMS Microbiol Ecol. 2020;96(10):fiaa176. https://doi.org/10.1093/femsec/fiaa176
32. Pulami D, Kämpfer P, Glaeser SP. High diversity of the emerging pathogen Acinetobacter baumannii and other Acinetobacter spp. in raw manure, biogas plants digestates, and rural and urban wastewater treatment plants with system specific antimicrobial resistance profiles. Sci Total Environ. 2023;859(1):160182. https://doi.org/10.1016/j.scitotenv.2022.160182
33. Sykes EME, Mateo-Estrada V, Zhanel G, Dettman J, Chapados J, Gerdis S, et al. Emergence of ADC-5 cephalosporinase in environmental Acinetobacter baumannii from a German tank milk with a novel sequence type. Access Microbiol. 2023;5(6):000485.v3. https://doi.org/10.1099/acmi.0.000485.v3
34. Jacobmeyer L, Stamm I, Semmler T, Ewers C. First report of NDM-1 in an Acinetobacter baumannii strain from a pet animal in Europe. J Glob Antimicrob Resist. 2021;26:128–129. https://doi.org/10.1016/j.jgar.2021.05.003
35. Rühl-Teichner J, Jacobmeyer L, Leidner U, Semmler T, Ewers C. Genomic diversity, antimicrobial susceptibility, and biofilm formation of clinical Acinetobacter baumannii isolates from horses in Germany. Microorganisms. 2023;11(3):556. https://doi.org/10.3390/microorganisms11030556
36. Wilharm G, Skiebe E, Higgins PG, Poppel MT, Blaschke U, Leser S, et al. Relatedness of wildlife and livestock avian isolates of the nosocomial pathogen Acinetobacter baumannii to lineages spread in hospitals worldwide. Environ Microbiol. 2017;19(10):4349–4364. https://doi.org/10.1111/1462-2920.13931
37. Jacobmeyer L, Semmler T, Stamm I, Ewers C. Genomic analysis of Acinetobacter baumannii isolates carrying OXA-23 and OXA-58 genes from animals reveals ST1 and ST25 as major clonal lineages. Antibiotics. 2022;11(8):1045. https://doi.org/10.3390/antibiotics11081045
38. Mertins S, Higgins PG, González Rodríguez M, Borlon C, Gilleman Q, Mertens P, et al. Generation and selection of antibodies for a novel immunochromatographic lateral flow test to rapidly identify OXA-23-like-mediated carbapenem resistance in Acinetobacter baumannii. J Med Microbiol. 2019;68(7):1021–1032. https://doi.org/10.1099/jmm.0.001015
39. Cerezales M, Biniossek L, Gerson S, Xanthopoulou K, Wille J, Wohlfarth E, et al. Novel multiplex PCRs for detection of the most prevalent carbapenemase genes in Gram-negative bacteria within Germany. J Med Microbiol. 2021;70(3):001310. https://doi.org/10.1099/jmm.0.001310
40. Mertins S, Higgins PG, Thunissen C, Magein H, Gilleman Q, Mertens P, et al. Development of an immunochromatographic lateral flow assay to rapidly detect OXA-23-, OXA-40-, OXA-58- and NDM-mediated carbapenem resistance determinants in Acinetobacter baumannii. J Med Microbiol. 2023;72(4):001681. https://doi.org/10.1099/jmm.0.001681
41. Wareth G, Linde J, Hammer P, Splettstoesser WD, Pletz MW, Neubauer H, et al. Molecular characterization of German Acinetobacter baumannii isolates and multilocus sequence typing (MLST) analysis based on WGS reveals novel STs. Pathogens. 2021;10(6):690. https://doi.org/10.3390/pathogens10060690
42. Schlosser B, Weikert B, Fucini GB, Kohlmorgen B, Kola A, Weber A, et al. Risk factors for transmission of carbapenem-resistant Acinetobacter baumannii in outbreak situations: Results of a case-control study. BMC Infect Dis. 2024;24(1):120. https://doi.org/10.1186/s12879-024-09015-7
43. Hecht J, Eisfeld J, Baum JHJ, Wagner-Wiening C, Leuze D, Zimnitskaya Y, et al. An outbreak of carbapenem-resistant Acinetobacter baumannii in multiple federal states in Germany. Dtsch Arztebl Int. 2022;119(29–30):508–509. https://doi.org/10.3238/arztebl.m2022.0196
44. Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: An updated guideline for reporting systematic reviews. BMJ. 2021;372:n71. https://doi.org/10.1136/bmj.n71
45. Klotz P, Higgins PG, Schaubmar AR, Failing K, Leidner U, Seifert H, et al. Seasonal occurrence and carbapenem susceptibility of bovine Acinetobacter baumannii in Germany. Front Microbiol. 2019;10:272. https://doi.org/10.3389/fmicb.2019.00272
46. Schmitz A, Hanke D, Lüschow D, Schwarz S, Higgins PG, Feßler AT. Acinetobacter baumannii from samples of commercially reared turkeys: Genomic relationships, antimicrobial and biocide susceptibility. Microorganisms. 2023;11(3):759. https://doi.org/10.3390/microorganisms11030759
47. Rühl-Teichner J, Müller D, Stamm I, Göttig S, Leidner U, Semmler T, et al. Inhibitory effect of antimicrobial peptides Bac7(17), PAsmr5-17 and PAβN on bacterial growth and biofilm formation of multidrug-resistant Acinetobacter baumannii. Microorganisms. 2025;13(3):639. https://doi.org/10.3390/microorganisms13030639
48. Unger F, Eisenberg T, Prenger-Berninghoff E, Leidner U, Semmler T, Ewers C. Imported pet reptiles and their "blind passengers"—in-depth characterization of 80 Acinetobacter species isolates. Microorganisms. 2022; 10(5):965. https://doi.org/10.3390/microorganisms10050893
49. Wareth G, Linde J, Hammer P, Nguyen NH, Nguyen TNM, Splettstoesser WD, et al. Phenotypic and WGS-derived antimicrobial resistance profiles of clinical and non-clinical Acinetobacter baumannii isolates from Germany and Vietnam. Int J Antimicrob Agents. 2020;56(4):106127. https://doi.org/10.1016/j.ijantimicag.2020.106127
50. Hembach N, Alexander J, Hiller C, Wieland A, Schwartz T. Dissemination prevention of antibiotic resistant and facultative pathogenic bacteria by ultrafiltration and ozone treatment at an urban wastewater treatment plant. Sci Rep. 2019;9(1):12843. https://doi.org/10.1038/s41598-019-49263-1
51. Savin M, Bierbaum G, Hammerl JA, Heinemann C, Parcina M, Sib E, et al. ESKAPE bacteria and extended-spectrum-β-lactamase-producing Escherichia coli isolated from wastewater and process water from German poultry slaughterhouses. Appl Environ Microbiol. 2020;86(8):02748-19. https://doi.org/10.1128/AEM.02748-19
52. Sykes EME, Mateo-Estrada V, Engelberg R, Muzaleva A, Zhanel G, Dettman J, et al. Phylogenomic and phenotypic analyses highlight the diversity of antibiotic resistance and virulence in both human and non-human Acinetobacter baumannii. mSphere. 2024;9(3):0074123. https://doi.org/10.1128/msphere.00741-23
53. Savin M, Alexander J, Bierbaum G, Hammerl JA, Hembach N, Schwartz T, et al. Antibiotic-resistant bacteria, antibiotic resistance genes, and antibiotic residues in wastewater from a poultry slaughterhouse after conventional and advanced treatments. Sci Rep. 2021;11(1):16622. https://doi.org/10.1038/s41598-021-96169-y
54. Forbes S, Prenger-Berninghoff E, Ewers C, Doelle M, Roethig A. Presence of methicillin-resistant staphylococci and carbapenemase-positive Acinetobacter isolates on surfaces in German dog daycare facilities and correlation with cleaning practices. Vet Sci. 2024;11(11):568. https://doi.org/10.3390/vetsci11110568
55. G, Abdel-Glil MY, Schmoock G, Steinacker U, Kaspar H, Neubauer H, et al. Draft genome sequence of an Acinetobacter baumannii isolate recovered from a horse with conjunctivitis in Germany. Microbiol Resour Announc. 2019;8(48):01128-19. https://doi.org/10.1128/MRA.01128-19
56. GBD 2021 Antimicrobial Resistance Collaborators. Global burden of bacterial antimicrobial resistance 1990–2021: A systematic analysis with forecasts to 2050. Lancet. 2024;404(10459):1199–1226. https://doi.org/10.1016/S0140-6736(24)01867-1
Veröffentlicht
Ausgabe
Rubrik
Lizenz
Copyright (c) 2026 Mohamed Hassan, Marwa Bassiouny, Oliver Shey-Njila (Author)
Dieses Werk steht unter der Lizenz Creative Commons Namensnennung - Nicht-kommerziell 4.0 International.
